How to Distinguish Neurodermatitis from Paederus Dermatitis

Neurodermatitis and paederus dermatitis are two distinct inflammatory skin conditions with markedly different etiologies, clinical presentations, and management strategies—though they may occasionally be confused due to overlapping features such as pruritus and erythematous plaques.

Neurodermatitis—also known as lichen simplex chronicus—is a chronic, stress- or habit-induced pruritic dermatosis characterized by localized, thickened, hyperpigmented, and lichenified plaques. It most commonly affects the nape of the neck, extensor surfaces of the wrists and ankles, and the anogenital region. The pathophysiology involves a self-perpetuating itch-scratch cycle: recurrent scratching leads to epidermal hyperplasia, acanthosis, and fibrosis, which in turn intensify pruritus. Diagnosis is primarily clinical; histopathology reveals hyperkeratosis, acanthosis, and increased dermal fibrosis without evidence of infection or toxin exposure. Management centers on breaking the itch-scratch cycle through high-potency topical corticosteroids, intralesional corticosteroid injections, behavioral interventions, and, when indicated, neuromodulators such as gabapentin or selective serotonin reuptake inhibitors (SSRIs) for underlying anxiety or obsessive-compulsive traits.

In contrast, paederus dermatitis is an acute irritant contact dermatitis caused by exposure to pederin—a potent vesicant toxin secreted by beetles of the genus Paederus, particularly P. fuscipes and P. riparius. The condition arises not from a bite or sting, but from accidental crushing of the insect on the skin—releasing pederin onto the epidermis. Clinically, it presents 24–48 hours after exposure with sharply demarcated, linear or geometric erythema, followed rapidly by vesicles, bullae, and superficial necrosis. Lesions often appear on exposed areas such as the face, neck, arms, or dorsum of hands—and may exhibit a characteristic “kissing lesion” pattern where adjacent skin surfaces (e.g., eyelids or flexural folds) come into contact with contaminated skin. Histopathology shows epidermal necrosis, spongiosis, and a neutrophilic infiltrate, reflecting direct cytotoxic injury rather than immune-mediated inflammation. Treatment is supportive: gentle cleansing, cool compresses, and mid-potency topical corticosteroids to reduce inflammation; systemic antibiotics are reserved only for secondary bacterial infection. Prevention hinges on avoiding insect contact—especially during warm, humid months—and promptly washing exposed skin if contact is suspected.

Key distinguishing features include onset (acute vs. chronic), trigger (toxin exposure vs. psychogenic/behavioral factors), morphology (geometric, vesiculobullous lesions vs. lichenified plaques), and histopathologic findings (epidermal necrosis vs. acanthosis/fibrosis). Accurate differentiation is essential—not only for appropriate therapy but also for patient counseling regarding prognosis and prevention.